Congratulations to all co-authors!
Our latest paper was just published in PNAS, titled "Restoration of atypical protein kinase C ζ function in autosomal dominant polycystic kidney disease ameliorates disease progression."

By Sonia Fernandez

Tuesday, May 17, 2022 - 14:45

Santa Barbara, CA

UC Santa Barbara molecular biologist Thomas Weimbs, left, recently welcomed Glenn Frommer, right, to the campus as the latter whizzed through Santa Barbara on a 5,300 mile Ride for PKD. The Weimbs Lab was one of the stops on this ambitious bicycle odyssey to raise awareness and research funding to find a treatment for polycystic kidney disease, which affects 600,000 Americans and more than 12.4 million people globally.

This was a collaboration with a research group in Thailand. Congratulations to all the authors.

Congratulations to all authors!

Strubl S, Oehm S, Torres JA, Grundmann F, Haratani J, Decker M, Vuong S, Bhandal AK, Methot N, Haynie-Cion R, Meyer F, Siedek F, Korst U, Müller RU, Weimbs T. Ketogenic Dietary Interventions in Autosomal-Dominant Polycystic Kidney Disease (ADPKD)– A Retrospective Case Series Study: First insights into Feasibility, Safety and Effects. Clinical Kidney Journal (in press). 2021